These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1032911)

  • 1. Cellular immune deficiency in patients with glioblastoma.
    Young HF; Kaplan AM
    Surg Forum; 1976; 27(62):476-8. PubMed ID: 1032911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P; Lapras C
    Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS
    Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immune response in brain tumors.
    Streit WJ
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):205-6. PubMed ID: 8072665
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of brain tumors--is there a future?
    Mahaley MS
    Clin Neurosurg; 1978; 25():382-7. PubMed ID: 710003
    [No Abstract]   [Full Text] [Related]  

  • 8. Harnessing the immune system against human glioma.
    Dhodapkar KM; Banerjee D; Steinman RM
    Ann N Y Acad Sci; 2005 Dec; 1062():13-21. PubMed ID: 16461784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune response in rats immunized with chemically modified syngeneic glioma cells. Monitoring by in vivo parameters and in vitro immune cytolysis.
    Bilzer T; Stavrou D; Dahme E; Anzil AP
    Anticancer Res; 1982; 2(6):345-54. PubMed ID: 6984814
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological reactions to gliomas.
    Ridley A
    Mod Trends Neurol; 1975; 6():249-66. PubMed ID: 1105142
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].
    Novichenko NL; Romodanov AP; Zhmareva EN; Gorovoĭ AI
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):9-13. PubMed ID: 6741378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia and tumor rejection.
    Frei K; Malipiero U; Piani D; Fontana A
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):206-8. PubMed ID: 8072666
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenetic control of the immune response to gliosarcoma 9L growth in rats.
    Geyer SJ; Landay A
    Transplant Proc; 1981 Jun; 13(2):1407-9. PubMed ID: 7245333
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.
    Mahaley MS; Brooks WH; Roszman TL; Bigner DD; Dudka L; Richardson S
    J Neurosurg; 1977 Apr; 46(4):467-76. PubMed ID: 191575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recording of cell-mediated immunity in patients with gliomatous brain tumors].
    Lambrecht R; Willenberg E; Plate M
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(3):167-71. PubMed ID: 3751205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral and cellular immunity in patients with left- and right-sided intracerebral tumors].
    Lisianyĭ NI; Markova OV; Prikhodchenko IA; Primushko LI
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):33-5. PubMed ID: 2787570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack.
    Gately CL; Muul LM; Greenwood MA; Papazoglou S; Dick SJ; Kornblith PL; Smith BH; Gately MK
    J Immunol; 1984 Dec; 133(6):3387-95. PubMed ID: 6238097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of CD4+CD45RA+ lymphocytes in patients with glioblastoma multiforme.
    Ménage P; Thibault G; Lebranchu Y; Jan M; Bardos P
    Eur J Med; 1992 Oct; 1(6):362-4. PubMed ID: 1285221
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological aspects of experimental brain tumors (review).
    Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
    Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunology of brain tumors: immunological situation of the brain].
    Tanaka R; Sobue H
    No To Shinkei; 1983 May; 35(5):451-9. PubMed ID: 6354218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.